Interferon monotherapy for patients with chronic hepatitis C and normal serum aminotransferase levels at commencement of treatment.

doi:10.1007/s00535-003-1388-0

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

Interferon monotherapy for patients with chronic hepatitis C and normal serum aminotransferase levels at commencement of treatment.

Journal of gastroenterology - 1 Aug 2004

Mamori Satoshi, Suzuki Fumitaka, Hosaka Tetsuya, Akuta Norio, Someya Takashi, Kobayashi Masahiro, Tsubota Akihito, Suzuki Yoshiyuki, Saitoh Satoshi, Arase Yasuji, Ikeda Kenji, Kumada Hiromitsu

Abstract excerpt

BACKGROUND: Approximately 30% of patients with chronic hepatitis C have normal serum alanine amino transferase (ALT) levels. While interferon (IFN) monotherapy is approved for patients with chronic hepatitis C infection, the effectiveness of such therapy for chronic hepatitis C patients with normal ALT levels at commencement of treatment remains poorly understood. METHODS: Ninety-four individuals (M/F, 54 : 40;...

Topics

Adolescent
Adult
Aged
Alanine Transaminase
Biopsy
Female
Genotype
Hepacivirus
Hepatitis C, Chronic
Humans
Interferon Type I

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Liver

Liver Function Tests

Male

Mathematical Computing

Middle Aged

Multivariate Analysis

Prognosis

Source

Open in PubMed

Identifiers

PMID: 15338372
DOI: 10.1007/s00535-003-1388-0

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Interferon monotherapy for patients with chronic hepatitis C and normal serum aminotransferase levels at commencement of treatment.PMID 15338372Read ↗

Interferon-alpha therapy for individuals with normal serum alanine aminotransferase levels before treatment.Semantic proximity Read ↗

Daily interferon monotherapy for chronic hepatitis C in patients with normal or near-normal serum alanine transaminase levels: a comparison of two protocols.Semantic proximity Read ↗

Therapy of hepatitis C: patients with normal aminotransferase levels.Semantic proximity Read ↗

IFN-alpha2b monotherapy in patients with chronic hepatitis C and persistently normal or near normal aminotransferase activity: a randomized, controlled study.Semantic proximity Read ↗

Therapy of hepatitis C: from empiricism to eradication.Semantic proximity Read ↗

Pegylated interferon-alpha2b plus ribavirin for the treatment of chronic hepatitis C virus genotype 4 infection in patients with normal serum ALT.Semantic proximity Read ↗

Current therapy for hepatitis C.Semantic proximity Read ↗

Sustained virological response rates and health-related quality of life after interferon and ribavirin therapy in patients with chronic hepatitis C virus infection and persistently normal alanine aminotransferase levels.Semantic proximity Read ↗

Alanine aminotransferase normalization at week 8 predicts viral response during hepatitis C treatment.Semantic proximity Read ↗

[Antiviral treatment of hepatitis C virus infection].Semantic proximity Read ↗

Factors predictive of a beneficial response to therapy of hepatitis C.Semantic proximity Read ↗

High-dose prolonged combination therapy in non-responders to interferon monotherapy for chronic hepatitis C.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.